Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer

被引:10
|
作者
Valdes, Alberto [1 ,2 ]
Bitzios, Athanasios [1 ]
Kassa, Eszter [1 ]
Shevchenko, Ganna [1 ]
Falk, Alexander [1 ]
Malmstrom, Per-Uno [3 ]
Dragomir, Anca [4 ,5 ]
Segersten, Ulrika [3 ]
Lind, Sara Bergstrom [1 ]
机构
[1] Uppsala Univ, Dept Chem BMC, Analyt Chem, Box 599, S-75124 Uppsala, Sweden
[2] CSIC, Lab Food, Inst Food Sci Res, CIAL, Nicolas Cabrera 9, Madrid 28049, Spain
[3] Uppsala Univ, Akad Hosp, Dept Surg Sci, Urol, S-75185 Uppsala, Sweden
[4] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[5] Uppsala Univ Hosp, Dept Pathol, S-75185 Uppsala, Sweden
基金
瑞典研究理事会; 奥地利科学基金会;
关键词
MASS-SPECTROMETRY; THERAPEUTIC TARGET; CARCINOMA; EXPRESSION; PATHWAYS; CELLS; TUFM;
D O I
10.1038/s41598-021-87003-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Samples in biobanks are generally preserved by formalin-fixation and paraffin-embedding (FFPE) and/or optimal cutting temperature compound (OCT)-embedding and subsequently frozen. Mass spectrometry (MS)-based analysis of these samples is now available via developed protocols, however, the differences in results with respect to preservation methods needs further investigation. Here we use bladder urothelial carcinoma tissue of two different tumor stages (Ta/T1-non-muscle invasive bladder cancer (NMIBC), and T2/T3-muscle invasive bladder cancer (MIBC)) which, upon sampling, were divided and preserved by FFPE and OCT. Samples were parallel processed from the two methods and proteins were analyzed with label-free quantitative MS. Over 700 and 1200 proteins were quantified in FFPE and OCT samples, respectively. Multivariate analysis indicates that the preservation method is the main source of variation, but also tumors of different stages could be differentiated. Proteins involved in mitochondrial function were overrepresented in OCT data but missing in the FFPE data, indicating that these proteins are not well preserved by FFPE. Concordant results for proteins such as HMGCS2 (uniquely quantified in Ta/T1 tumors), and LGALS1, ANXA5 and plastin (upregulated in T2/T3 tumors) were observed in both FFPE and OCT data, which supports the use of MS technology for biobank samples and encourages the further evaluation of these proteins as biomarkers.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer
    Alberto Valdés
    Athanasios Bitzios
    Eszter Kassa
    Ganna Shevchenko
    Alexander Falk
    Per-Uno Malmström
    Anca Dragomir
    Ulrika Segersten
    Sara Bergström Lind
    Scientific Reports, 11
  • [2] Current look at the most promising proteomic and glycomic biomarkers of bladder cancer
    Harsanyi, Stefan
    Kianickova, Kristina
    Katrlik, Jaroslav
    Danisovic, Lubos
    Ziaran, Stanislav
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (02)
  • [3] Current look at the most promising proteomic and glycomic biomarkers of bladder cancer
    Stefan Harsanyi
    Kristina Kianickova
    Jaroslav Katrlik
    Lubos Danisovic
    Stanislav Ziaran
    Journal of Cancer Research and Clinical Oncology, 150
  • [4] Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers
    Schwamborn, Kristina
    Gaisa, Nadine T.
    Henkel, Corinna
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (06) : 897 - 906
  • [5] Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity
    Samira Tabaei
    Mohammad Reza Haghshenas
    Ali Ariafar
    Kambiz Gilany
    Allan Stensballe
    Shirin Farjadian
    Abbas Ghaderi
    Clinical Proteomics, 2023, 20
  • [6] Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity
    Tabaei, Samira
    Haghshenas, Mohammad Reza
    Ariafar, Ali
    Gilany, Kambiz
    Stensballe, Allan
    Farjadian, Shirin
    Ghaderi, Abbas
    CLINICAL PROTEOMICS, 2023, 20 (01)
  • [7] COMPARISON BETWEEN DIFFERENT METHODS OF LEVEL IDENTIFICATION
    Pfante, Oliver
    Bertschinger, Nils
    Olbrich, Eckehard
    Ay, Nihat
    Jost, Juergen
    ADVANCES IN COMPLEX SYSTEMS, 2014, 17 (02):
  • [9] Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer
    Guo, Lu
    Zhang, Caixia
    Zhu, Jinghong
    Yang, Yuqin
    Lan, Jianfa
    Su, Gang
    Xie, Xiaodong
    LIFE SCIENCES, 2016, 151 : 102 - 108
  • [10] Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers
    Tomiyama, Eisuke
    Matsuzaki, Kyosuke
    Fujita, Kazutoshi
    Shiromizu, Takashi
    Narumi, Ryohei
    Jingushi, Kentaro
    Koh, Yoko
    Matsushita, Makoto
    Nakano, Kosuke
    Hayashi, Yujiro
    Wang, Cong
    Ishizuya, Yu
    Kato, Taigo
    Hatano, Koji
    Kawashima, Atsunari
    Ujike, Takeshi
    Uemura, Motohide
    Takao, Tetsuya
    Adachi, Jun
    Tomonaga, Takeshi
    Nonomura, Norio
    CANCER SCIENCE, 2021, 112 (05) : 2033 - 2045